Nanobiotix S.A.
NBTX • Biotechnology
$38.80
— 0.00 (0.00%)
EarningsLatest report: Dec 31, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.86B
Growth
-2.5%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 68.9%Weak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 31, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$38.80
Change0.00%
Shares Out47.82M
Market Cap$1.86B
52W Range4.18 - 57.14
Beta0.59
P/E-44.37
P/S35.87
P/B-12.58
P/FCF-31.30
EV/Sales33.18
EV/EBITDA-81.50
Price$38.80
Change0.00%
Shares Out47.82M
Market Cap$1.86B
52W Range4.18 - 57.14
Beta0.59
P/E-44.37
P/S35.87
P/B-12.58
P/FCF-31.30
EV/Sales33.18
EV/EBITDA-81.50
EV/FCF-28.95
Earnings Yield-2.25%
FCF Yield-3.19%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-36.49%
Profit Margin-80.83%
Debt/Eq-1.13
Current Ratio1.09
Quick Ratio1.09
Revenue 5Y-2.52%
Target$38.00
Target Upside-2.06%
Target Median$38.00
Target Range30.00 - 46.00
Volume109.53K
Avg Volume76.91K
EPS Surprise-0.76
Investment DNA
How strong this company looks for long-term investors
39
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
48/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Positive revenue growth · 68.9%Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
88/100
Bullish
Bullish
3
Hold
1
Bearish
0
Price Target
2026-06-10
Low
$30.00
Mean
$38.00
Median
$38.00
High
$46.00
🧾
No insider activity
No recent insider transactions available.